| Market Cap | ₹21,820Cr |
| ROE | -0.29% |
| P/E Ratio(TTM) | -133.46 |
| EPS(TTM) | -1.23 |
| P/B Ratio | 2.70 |
| Dividend Yield | 0.08% |
| Industry P/E | 32.33 |
| Book Value | 60.77 |
| Debt to Equity | 0.60 |
| Face Value | 10 |
| Founded | 2020 |
| NSE Symbol | PPLPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 37.47 | ||
| Cipla | NA (0.00%) | 24.05 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 19.20 | ||
| Lupin | NA (0.00%) | 23.22 |